{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:05:42Z","timestamp":1781611542289,"version":"3.54.5"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T00:00:00Z","timestamp":1688428800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T00:00:00Z","timestamp":1688428800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s00432-023-05064-8","type":"journal-article","created":{"date-parts":[[2023,7,4]],"date-time":"2023-07-04T04:02:06Z","timestamp":1688443326000},"page":"11619-11634","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Integrated analysis reveals SMARCD1 is a potential biomarker and therapeutic target in skin cutaneous melanoma"],"prefix":"10.1007","volume":"149","author":[{"given":"Jiaoquan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanji","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huilan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,4]]},"reference":[{"issue":"5","key":"5064_CR1","doi-asserted-by":"publisher","first-page":"4559","DOI":"10.1002\/jcp.29332","volume":"235","author":"R Adduri","year":"2020","unstructured":"Adduri R, George SA, Kavadipula P, Bashyam MD (2020) SMARCD1 is a transcriptional target of specific non-hotspot mutant p53 forms. J Cell Physiol 235(5):4559\u20134570","journal-title":"J Cell Physiol"},{"issue":"8","key":"5064_CR2","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1002\/cbin.10959","volume":"42","author":"H Akrami","year":"2018","unstructured":"Akrami H, Moradi B, Borzabadi FD, Mehdizadeh K (2018) Ibuprofen reduces cell proliferation through inhibiting Wnt\/beta catenin signaling pathway in gastric cancer stem cells. Cell Biol Int 42(8):949\u2013958","journal-title":"Cell Biol Int"},{"key":"5064_CR3","doi-asserted-by":"publisher","first-page":"0108301","DOI":"10.1016\/j.pharmthera.2022.108301","volume":"24","author":"I Anestopoulos","year":"2022","unstructured":"Anestopoulos I, Kyriakou S, Tragkola V, Paraskevaidis I, Tzika E, Mitsiogianni M, Deligiorgi MV, Petrakis G, Trafalis DT, Botaitis S, Giatromanolaki A, Koukourakis MI, Franco R, Pappa A, Panayiotidis MI (2022) Targeting the epigenome in malignant melanoma: Facts, challenges and therapeutic promises. Pharmacol Ther 24:0108301","journal-title":"Pharmacol Ther"},{"key":"5064_CR4","doi-asserted-by":"publisher","first-page":"426","DOI":"10.5694\/mja2.51910","volume":"218","author":"P Bhave","year":"2023","unstructured":"Bhave P, Wong J, McInerney-Leo A, Cust AE, Lawn C, Janda M, Mar VJ (2023) Management of cutaneous melanoma in Australia: a narrative review. Med J Aust 218:426","journal-title":"Med J Aust"},{"issue":"6","key":"5064_CR5","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394\u2013424","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"5064_CR6","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.mayocp.2022.10.029","volume":"98","author":"EH Campbell","year":"2023","unstructured":"Campbell EH, Reinhart JP, Crum OM, Proffer SL, Weaver A, Gibson LE, Brewer JD, Demer AM (2023) Increasing incidence and decreasing mortality of cutaneous melanoma in middle-aged adults: an epidemiologic study in Olmsted county, Minnesota. Mayo Clin Proc 98(5):713\u2013722","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"5064_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1002571","volume":"8","author":"L Chen","year":"2012","unstructured":"Chen L, Fulcoli FG, Ferrentino R, Martucciello S, Illingworth EA, Baldini A (2012) Transcriptional control in cardiac progenitors: Tbx1 interacts with the BAF chromatin remodeling complex and regulates Wnt5a. PLoS Genet 8(3):e1002571","journal-title":"PLoS Genet"},{"key":"5064_CR8","first-page":"4251","volume":"17","author":"P Donizy","year":"2022","unstructured":"Donizy P, Krzyzinski M, Markiewicz A, Karpinski P, Kotowski K, Kowalik A, Orlowska-Heitzman J, Romanowska-Dixon B, Biecek P, Hoang MP (2022) Machine learning models demonstrate that clinicopathologic variables are comparable to gene expression prognostic signature in predicting survival in uveal melanoma. Eur J Cancer 17:4251\u20134260","journal-title":"Eur J Cancer"},{"issue":"1","key":"5064_CR9","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1186\/s40425-019-0659-0","volume":"7","author":"A Forschner","year":"2019","unstructured":"Forschner A, Battke F, Hadaschik D, Schulze M, Weissgraeber S, Han CT, Kopp M, Frick M, Klumpp B, Tietze N, Amaral T, Martus P, Sinnberg T, Eigentler T, Keim U, Garbe C, Docker D, Biskup S (2019) Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma - results of a prospective biomarker study. J Immunother Cancer 7(1):180","journal-title":"J Immunother Cancer"},{"key":"5064_CR10","doi-asserted-by":"publisher","first-page":"0256","DOI":"10.1016\/j.ejca.2022.04.018","volume":"17","author":"C Garbe","year":"2022","unstructured":"Garbe C, Amaral T, Peris K, Hauschild A, Arenberger P, Basset-Seguin N, Bastholt L, Bataille V, Del MV, Dreno B, Fargnoli MC, Forsea AM, Grob JJ, Hoeller C, Kaufmann R, Kelleners-Smeets N, Lallas A, Lebbe C, Lytvynenko B, Malvehy J, Moreno-Ramirez D, Nathan P, Pellacani G, Saiag P, Stratigos AJ, van Akkooi A, Vieira R, Zalaudek I, Lorigan P (2022) European consensus-based interdisciplinary guideline for melanoma. Part 2: treatment-update 2022. Eur J Cancer 17:0256\u20130284","journal-title":"Eur J Cancer"},{"key":"5064_CR11","first-page":"26123","volume":"12","author":"SR Georgescu","year":"2020","unstructured":"Georgescu SR, Tampa M, Mitran CI, Mitran MI, Caruntu C, Caruntu A, Lupu M, Matei C, Constantin C, Neagu M (2020) Tumour microenvironment in skin carcinogenesis. Adv Exp Med Biol 12:26123\u201326142","journal-title":"Adv Exp Med Biol"},{"key":"5064_CR12","doi-asserted-by":"publisher","first-page":"985051","DOI":"10.3389\/fimmu.2022.985051","volume":"13","author":"S Guo","year":"2022","unstructured":"Guo S, Chen J, Yi X, Lu Z, Guo W (2022) Identification and validation of ferroptosis-related lncRNA signature as a prognostic model for skin cutaneous melanoma. Front Immunol 13:985051","journal-title":"Front Immunol"},{"key":"5064_CR13","first-page":"224782361","volume":"20","author":"B Han","year":"2022","unstructured":"Han B, Yang M, Liu Q, Wang G, Hou J (2022) Long noncoding RNA SBF2-AS1 promotes abdominal aortic aneurysm formation through the miRNA-520f-3p\/SMARCD1 axis. Dis Markers 20:224782361","journal-title":"Dis Markers"},{"issue":"17","key":"5064_CR14","doi-asserted-by":"publisher","first-page":"6210","DOI":"10.1128\/MCB.23.17.6210-6220.2003","volume":"23","author":"PW Hsiao","year":"2003","unstructured":"Hsiao PW, Fryer CJ, Trotter KW, Wang W, Archer TK (2003) BAF60a mediates critical interactions between nuclear receptors and the BRG1 chromatin-remodeling complex for transactivation. Mol Cell Biol 23(17):6210\u20136220","journal-title":"Mol Cell Biol"},{"key":"5064_CR15","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41514-017-0011-1","volume":"3","author":"C Inoue","year":"2017","unstructured":"Inoue C, Zhao C, Tsuduki Y, Udono M, Wang L, Nomura M, Katakura Y (2017) SMARCD1 regulates senescence-associated lipid accumulation in hepatocytes. NPJ Aging Mech Dis 3:11","journal-title":"NPJ Aging Mech Dis"},{"issue":"6","key":"5064_CR16","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/ng.2628","volume":"45","author":"C Kadoch","year":"2013","unstructured":"Kadoch C, Hargreaves DC, Hodges C, Elias L, Ho L, Ranish J, Crabtree GR (2013) Proteomic and bioinformatic analysis of mammalian SWI\/SNF complexes identifies extensive roles in human malignancy. Nat Genet 45(6):592\u2013601","journal-title":"Nat Genet"},{"key":"5064_CR17","doi-asserted-by":"publisher","first-page":"573141","DOI":"10.3389\/fonc.2020.573141","volume":"10","author":"K Kang","year":"2020","unstructured":"Kang K, Xie F, Mao J, Bai Y, Wang X (2020) Significance of tumor mutation burden in immune infiltration and prognosis in cutaneous melanoma. Front Oncol 10:573141","journal-title":"Front Oncol"},{"issue":"1","key":"5064_CR18","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1186\/s12935-022-02738-0","volume":"22","author":"FM Karami","year":"2022","unstructured":"Karami FM, Azargoonjahromi A, Soofi A, Almasi F, Hosseinzadeh S, Khalili S, Sheikhi K, Ferdousmakan S, Owrangi S, Fahimi M, Zalpoor H, Nabi AM, Payandeh Z, Pourzardosht N (2022) Current understanding of epigenetics role in melanoma treatment and resistance. Cancer Cell Int 22(1):313","journal-title":"Cancer Cell Int"},{"issue":"6","key":"5064_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2020.152947","volume":"216","author":"M Kwon","year":"2020","unstructured":"Kwon M, Hong JY, Kim ST, Kim KM, Lee J (2020) Association of serine\/threonine kinase 11 mutations and response to programmed cell death 1 inhibitors in metastatic gastric cancer. Pathol Res Pract 216(6):152947","journal-title":"Pathol Res Pract"},{"issue":"9","key":"5064_CR20","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.3390\/pharmaceutics14091817","volume":"14","author":"J Lopes","year":"2022","unstructured":"Lopes J, Rodrigues C, Gaspar MM, Reis CP (2022) How to treat melanoma? The current status of innovative nanotechnological strategies and the role of minimally invasive approaches like PTT and PDT. Pharmaceutics 14(9):1817","journal-title":"Pharmaceutics"},{"issue":"18","key":"5064_CR21","doi-asserted-by":"publisher","first-page":"11924","DOI":"10.1074\/jbc.M705401200","volume":"283","author":"J Oh","year":"2008","unstructured":"Oh J, Sohn DH, Ko M, Chung H, Jeon SH, Seong RH (2008) BAF60a interacts with p53 to recruit the SWI\/SNF complex. J Biol Chem 283(18):11924\u201311934","journal-title":"J Biol Chem"},{"issue":"1","key":"5064_CR22","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1038\/s41467-020-15546-9","volume":"11","author":"VW Rebecca","year":"2020","unstructured":"Rebecca VW, Somasundaram R, Herlyn M (2020) Pre-clinical modeling of cutaneous melanoma. Nat Commun 11(1):2858","journal-title":"Nat Commun"},{"issue":"1","key":"5064_CR23","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1006\/geno.1998.5343","volume":"51","author":"HZ Ring","year":"1998","unstructured":"Ring HZ, Vameghi-Meyers V, Wang W, Crabtree GR, Francke U (1998) Five SWI\/SNF-related, matrix-associated, actin-dependent regulator of chromatin (SMARC) genes are dispersed in the human genome. Genomics 51(1):140\u2013143","journal-title":"Genomics"},{"issue":"8","key":"5064_CR24","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1038\/s41418-018-0210-8","volume":"26","author":"J Rozanc","year":"2019","unstructured":"Rozanc J, Sakellaropoulos T, Antoranz A, Gutta C, Podder B, Vetma V, Rufo N, Agostinis P, Pliaka V, Sauter T, Kulms D, Rehm M, Alexopoulos LG (2019) Phosphoprotein patterns predict trametinib responsiveness and optimal trametinib sensitisation strategies in melanoma. Cell Death Differ 26(8):1365\u20131378","journal-title":"Cell Death Differ"},{"issue":"4","key":"5064_CR25","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1158\/0008-5472.CAN-14-1301","volume":"75","author":"J Shen","year":"2015","unstructured":"Shen J, Xiao Z, Wu WK, Wang MH, To KF, Chen Y, Yang W, Li MS, Shin VY, Tong JH, Kang W, Zhang L, Li M, Wang L, Lu L, Chan RL, Wong SH, Yu J, Chan MT, Chan FK, Sung JJ, Cheng AS, Cho CH (2015) Epigenetic silencing of miR-490-3p reactivates the chromatin remodeler SMARCD1 to promote Helicobacter pylori-induced gastric carcinogenesis. Cancer Res 75(4):754\u2013765","journal-title":"Cancer Res"},{"issue":"2","key":"5064_CR26","first-page":"161","volume":"85","author":"DW Shenenberger","year":"2012","unstructured":"Shenenberger DW (2012) Cutaneous malignant melanoma: a primary care perspective. Am Fam Physician 85(2):161\u2013168","journal-title":"Am Fam Physician"},{"issue":"12","key":"5064_CR27","doi-asserted-by":"publisher","first-page":"6395","DOI":"10.3390\/ijms22126395","volume":"22","author":"S Strashilov","year":"2021","unstructured":"Strashilov S, Yordanov A (2021) Aetiology and pathogenesis of cutaneous melanoma: current concepts and advances. Int J Mol Sci 22(12):6395","journal-title":"Int J Mol Sci"},{"issue":"3","key":"5064_CR28","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F (2021) Global cancer statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 71(3):209\u2013249","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"5064_CR29","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12958-020-00590-3","volume":"18","author":"K Takebayashi","year":"2020","unstructured":"Takebayashi K, Nasu K, Okamoto M, Aoyagi Y, Hirakawa T, Narahara H (2020) hsa-miR-100-5p, an overexpressed miRNA in human ovarian endometriotic stromal cells, promotes invasion through attenuation of SMARCD1 expression. Reprod Biol Endocrinol 18(1):31","journal-title":"Reprod Biol Endocrinol"},{"issue":"6","key":"5064_CR30","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1002\/1878-0261.13192","volume":"16","author":"M Tamai","year":"2022","unstructured":"Tamai M, Tatarano S, Okamura S, Fukumoto W, Kawakami I, Osako Y, Sakaguchi T, Sugita S, Yonemori M, Yamada Y, Nakagawa M, Enokida H, Yoshino H (2022) microRNA-99a-5p induces cellular senescence in gemcitabine-resistant bladder cancer by targeting SMARCD1. Mol Oncol 16(6):1329\u20131346","journal-title":"Mol Oncol"},{"key":"5064_CR31","first-page":"5158","volume":"17","author":"S Voglis","year":"2022","unstructured":"Voglis S, Schaller V, Muller T, Gonel M, Winklhofer S, Mangana J, Dummer R, Serra C, Weller M, Regli L, Le Rhun E, Neidert MC (2022) Maximal surgical tumour load reduction in immune-checkpoint inhibitor naive patients with melanoma brain metastases correlates with prolonged survival. Eur J Cancer 17:5158\u20135168","journal-title":"Eur J Cancer"},{"issue":"9","key":"5064_CR32","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1093\/annonc\/mdz197","volume":"30","author":"F Wang","year":"2019","unstructured":"Wang F, Wei XL, Wang FH, Xu N, Shen L, Dai GH, Yuan XL, Chen Y, Yang SJ, Shi JH, Hu XC, Lin XY, Zhang QY, Feng JF, Ba Y, Liu YP, Li W, Shu YQ, Jiang Y, Li Q, Wang JW, Wu H, Feng H, Yao S, Xu RH (2019) Safety, efficacy and tumor mutational burden as a biomarker of overall survival benefit in chemo-refractory gastric cancer treated with toripalimab, a PD-1 antibody in phase Ib\/II clinical trial NCT02915432. Ann Oncol 30(9):1479\u20131486","journal-title":"Ann Oncol"},{"key":"5064_CR33","doi-asserted-by":"publisher","first-page":"570654","DOI":"10.3389\/fonc.2020.570654","volume":"10","author":"J Yan","year":"2020","unstructured":"Yan J, Wu X, Yu J, Zhu Y, Cang S (2020) Prognostic role of tumor mutation burden combined with immune infiltrates in skin cutaneous melanoma based on multi-omics analysis. Front Oncol 10:570654","journal-title":"Front Oncol"},{"issue":"7","key":"5064_CR34","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.annonc.2020.03.299","volume":"31","author":"T Yoshino","year":"2020","unstructured":"Yoshino T, Pentheroudakis G, Mishima S, Overman MJ, Yeh KH, Baba E, Naito Y, Calvo F, Saxena A, Chen LT, Takeda M, Cervantes A, Taniguchi H, Yoshida K, Kodera Y, Kitagawa Y, Tabernero J, Burris H, Douillard JY (2020) JSCO-ESMO-ASCO-JSMO-TOS: international expert consensus recommendations for tumour-agnostic treatments in patients with solid tumours with microsatellite instability or NTRK fusions. Ann Oncol 31(7):861\u2013872","journal-title":"Ann Oncol"},{"key":"5064_CR35","doi-asserted-by":"publisher","first-page":"1170190","DOI":"10.3389\/fonc.2023.1170190","volume":"13","author":"L Zhang","year":"2023","unstructured":"Zhang L, Shi Z, Zhang F, Chen B, Qiu W, Cai L, Lin X (2023) Ubiquitination-related biomarkers in metastatic melanoma patients and their roles in tumor microenvironment. Front Oncol 13:1170190","journal-title":"Front Oncol"},{"issue":"12","key":"5064_CR36","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1042\/CS20200244","volume":"134","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Xu Q, Tao L, Chen Y, Shu Y, Wu Z, Lu C, Shi Y, Bu H (2020) Enhanced SMARCD1, a subunit of the SWI\/SNF complex, promotes liver cancer growth through the mTOR pathway. Clin Sci (lond) 134(12):1457\u20131472","journal-title":"Clin Sci (lond)"},{"key":"5064_CR37","doi-asserted-by":"publisher","first-page":"990749","DOI":"10.3389\/fsurg.2022.990749","volume":"9","author":"S Zhou","year":"2022","unstructured":"Zhou S, Han Y, Yang R, Pi X, Li J (2022) TIMM13 as a prognostic biomarker and associated with immune infiltration in skin cutaneous melanoma (SKCM). Front Surg 9:990749","journal-title":"Front Surg"},{"issue":"4","key":"5064_CR38","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1007\/s12035-020-02190-z","volume":"58","author":"Y Zhu","year":"2021","unstructured":"Zhu Y, Wang H, Fei M, Tang T, Niu W, Zhang L (2021) Smarcd1 inhibits the malignant phenotypes of human glioblastoma cells via crosstalk with Notch1. Mol Neurobiol 58(4):1438\u20131452","journal-title":"Mol Neurobiol"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-05064-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00432-023-05064-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-023-05064-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T09:12:49Z","timestamp":1693300369000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00432-023-05064-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,4]]},"references-count":38,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["5064"],"URL":"https:\/\/doi.org\/10.1007\/s00432-023-05064-8","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,4]]},"assertion":[{"value":"7 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests for this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The studies involving human participants were reviewed and approved by Ethics Committee of Shanghai Wellbio biotechnology Company Limited.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}]}}